Israel Englander Biom X Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.21 - $0.69 $4,150 - $13,636	19,763 New	19,763 $8,000
Q2 2023 Aug 14, 2023	BUY	$0.25 - $0.42 $3,146 - $5,285	12,584 Added 37.83%	45,850 $16,000
Q1 2023 May 15, 2023	SELL	$0.18 - $0.57 $42,764 - $135,421	-237,582 Reduced 87.72%	33,266 $10,000
Q4 2022 Feb 14, 2023	BUY	$0.14 - $4.52 $25,632 - $827,571	183,091 Added 208.63%	270,848 $51,000
Q3 2022 Nov 14, 2022	BUY	$0.05 - $10.7 $441 - $94,416	8,824 Added 11.18%	87,757 $30,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $20.2 $117,900 - $372,124	-18,422 Reduced 18.92%	78,933 $58,000
Q1 2022 May 16, 2022	SELL	$12.1 - $20.6 $771,483 - $1.31 Million	-63,759 Reduced 39.57%	97,355 $188,000
Q4 2021 Feb 14, 2022	SELL	$14.4 - $30.4 $1.93 Million - $4.08 Million	-134,061 Reduced 45.42%	161,114 $258,000
Q3 2021 Nov 15, 2021	SELL	$30.6 - $58.1 $4.06 Million - $7.7 Million	-132,527 Reduced 30.99%	295,175 $903,000
Q2 2021 Aug 16, 2021	SELL	$52.6 - $72.5 $1.4 Million - $1.93 Million	-26,675 Reduced 5.87%	427,702 $2.34 Million
Q1 2021 May 17, 2021	SELL	$63.1 - $86.4 $357,777 - $489,888	-5,670 Reduced 1.23%	454,377 $3.24 Million
Q4 2020 Feb 16, 2021	BUY	$56.0 - $66.7 $2.51 Million - $2.98 Million	44,751 Added 10.78%	460,047 $2.94 Million
Q3 2020 Nov 16, 2020	BUY	$51.3 - $86.5 $6.14 Million - $10.4 Million	119,681 Added 40.49%	415,296 $2.63 Million
Q2 2020 Aug 14, 2020	BUY	$47.1 - $78.0 $6.81 Million - $11.3 Million	144,654 Added 95.82%	295,615 $1.63 Million
Q1 2020 May 14, 2020	BUY	$61.2 - $104.4 $9.24 Million - $15.8 Million	150,961 New	150,961 $1.06 Million

Others Institutions Holding PHGE

# of Institutions

Shares Held

301K

Call Options Held

Put Options Held

View Full List

About BiomX Inc.

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $19.2M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

More about PHGE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account